Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|1||Details of the person discharging managerial responsibilities / person closely associated|
|a)||Name||1. Amjad Bseisu
2. Jonathan Swinney
3. Martin Houston
4. Howard Paver
5. Phil Holland
6. Carl Hughes
7. Farina Khan
8. John Winterman
9. Double A Limited
10. The Amjad & Suha Bseisu Foundation
|2||Reason for the notification|
4. Senior Independent Director
5. Non-Executive Director
6. Non-Executive Director
7. Non-Executive Director
8. Non-Executive Director
9. Double A Limited is a company beneficially owned by the extended family of Amjad Bseisu (CEO of EnQuest PLC).
10. A registered charity, of which Amjad Bseisu (CEO of EnQuest PLC) is a Trustee.
|b)||Initial notification /Amendment||Initial notification|
|3||Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor|
|4||Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted|
|a)||Description of the financial instrument, type of instrument||£0.05 ordinary shares|
|b)||Nature of the transaction||Take up of Open Offer shares (5 new shares for every 89 existing shares)|
|c)||Price(s) and volume(s)|
Following these transactions, Amjad Bseisu, Double A Limited and the Amjad & Suha Bseisu Foundation collectively have shareholdings totalling 209,930,959 shares.
Please note that John Winterman’s total shareholding is 21,123. It has been previously misstated as 28,571.
|d)||Aggregated information- Aggregated volume- Price||n/a|
|e)||Date of the transaction||26 July 2021|
|f)||Place of the transaction||London Stock Exchange (XLON)|
For further information please contact:
EnQuest PLC Tel: +44 (0)20 7925 4900
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact firstname.lastname@example.org or visit www.rns.com.